Rabbit IgG anti-Sheep IgG (H+L)-FITC, MinX Hu

Artikelnummer: DNA-SEC-183545
Artikelname: Rabbit IgG anti-Sheep IgG (H+L)-FITC, MinX Hu
Artikelnummer: DNA-SEC-183545
Hersteller Artikelnummer: SEC-183545
Alternativnummer: DNA-SEC-183545
Hersteller: dianova
Wirt: Rabbit
Kategorie: Antikörper
Applikation: FLISA,FACS,IF
Spezies Reaktivität: Sheep
Immunogen: Sheep IgG whole molecule
Konjugation: FITC
Alternative Synonym: Rabbit Anti-Sheep IgG fluorescein Conjugated Antibody, Rabbit Anti-Sheep IgG Antibody FITC Conjugation
Format: IgG
Spezifität: IgG (H+L)
Minimale Kreuzreaktivität (MinX): Human
FITC Conjugated Secondary Antibody is designed for flow cytometry, immunofluorescence microscopy, fluorescence based plate assays (FLISA) and fluorescent western blotting. This product is also suitable for multiplex analysis, including multicolor imaging
Klonalität: Polyclonal
Konzentration: 1.0 mg/mL
Isotyp: Ig
Puffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Reinheit: Sheep IgG (H&L) Secondary Antibody Fluorescein Conjugated Pre-Adsorbed was prepared from monospecific antiserum by immunoaffinity chromatography using Sheep IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities.   Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-Fluorescein, anti-Rabbit Serum, Sheep IgG and Sheep Serum.  No reaction was observed against Human Serum Proteins.
Formulierung: Lyophilized
Formel: 20 mM K3PO4,150 mM NaCl,pH 7,2,lyophilisate,0,01% NaN3
Target-Kategorie: Sheep
Antibody Type: Secondary Antibody
Application Verdünnung: FLISA Dilution: 1:10,000 - 1:50,000, Flow Cytometry Dilution: 1:500 - 1:2,500, Fluorochrome Protein Value: 3.0, IF Microscopy Dilution: 1:1,000 - 1:5,000
Anwendungsbeschreibung: Anti-Sheep Secondary Antibody is designed for immunofluorescence microscopy, fluorescence based plate assays (FLISA) and fluorescent western blotting. This product is also suitable for multiplex analysis, including multicolor imaging, utilizing various commercial platforms.